Bhandari, Jayant, et al. “Compound 186 Is a Negative Allosteric Modulator of Dopamine D2 Receptors: Implications for Improving Schizophrenia Therapy”. The Meducator, vol. 1, no. 22, May 2013, doi:10.15173/m.v1i22.818.